Bridgewater Associates’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,685
| Closed | -$552K | – | 699 |
|
|
2024
Q3 | $552K | Sell |
19,685
-20,632
| -51% | -$579K | ﹤0.01% | 679 |
|
|
2024
Q2 | $918K | Sell |
40,317
-5,692
| -12% | -$130K | ﹤0.01% | 677 |
|
|
2024
Q1 | $1.4M | Buy |
46,009
+25,579
| +125% | +$778K | 0.01% | 540 |
|
|
2023
Q4 | $729K | Sell |
20,430
-1,517
| -7% | -$54.1K | ﹤0.01% | 673 |
|
|
2023
Q3 | $961K | Sell |
21,947
-38,723
| -64% | -$1.7M | 0.01% | 612 |
|
|
2023
Q2 | $2.99M | Sell |
60,670
-4,676
| -7% | -$231K | 0.02% | 407 |
|
|
2023
Q1 | $2.71M | Buy |
65,346
+11,732
| +22% | +$486K | 0.02% | 416 |
|
|
2022
Q4 | $2.38M | Sell |
53,614
-18,248
| -25% | -$810K | 0.01% | 501 |
|
|
2022
Q3 | $2.81M | Buy |
71,862
+93
| +0.1% | +$3.64K | 0.01% | 490 |
|
|
2022
Q2 | $2.93M | Buy |
71,769
+6,983
| +11% | +$285K | 0.01% | 605 |
|
|
2022
Q1 | $4.25M | Buy |
64,786
+15,930
| +33% | +$1.05M | 0.02% | 509 |
|
|
2021
Q4 | $3.4M | Buy |
48,856
+6,926
| +17% | +$482K | 0.02% | 380 |
|
|
2021
Q3 | $2.92M | Sell |
41,930
-1,494
| -3% | -$104K | 0.02% | 374 |
|
|
2021
Q2 | $3.45M | Buy |
+43,424
| New | +$3.45M | 0.02% | 401 |
|